Solution structure of CXCL5 - A novel chemokine and adipokine implicated in inflammation and obesity

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Sepuru, Krishna Mohan ^a   Poluri, Krishna Mohan ^a   Rajarathnam, Krishna ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GLYCOSAMINOGLYCAN; CXCL5 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; INFLAMMATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; CHEMISTRY; GENETICS; HUMAN; METABOLISM; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE;

ADIPOKINES; AMINO ACID MOTIFS; CHEMOKINE CXCL5; HUMANS; INFLAMMATION; OBESITY; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY;

EID: 84898860467     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093228     Document Type: Article

References (64)

1. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127. (Pubitemid 30398626)
2. Fernandez EJ, Lolis E (2002) Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 42: 469-499. (Pubitemid 34160533)
3. Bonecchi R, Galliera E, Borroni EM, Corsi MM, Locati M, et al. (2009) Chemokines and chemokine receptors: an overview. Front Biosci 14: 540-551.
4. O'Hayre M, Salanga CL, Handel TM, Allen SJ (2008) Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J 409: 635-649. (Pubitemid 351214190)
5. Stillie R, Farooq SM, Gordon JR, Stadnyk AW (2009) The functional significance behind expressing two IL-8 receptor types on PMN. J Leukoc Biol 86: 529-543.
6. Jeyaseelan S, Manzer R, Young SK, Yamamoto M, Akira S, et al. (2005) Induction of CXCL5 during inflammation in the rodent lung involves activation of alveolar epithelium. Am J Respir Cell Mol Biol 32: 531-539. (Pubitemid 40770131)
7. Mei J, Liu Y, Dai N, Favara M, Greene T, et al. (2010) CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection. Immunity 33: 106-117.
8. Chavey C, Lazennec G, Lagarrigue S, Clapé C, Iankova I, et al. (2009) CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance. Cell Metab 9: 339-349.
9. Chavey C, Fajas L (2009) CXCL5 drives obesity to diabetes, and further. Aging (Albany NY) 1: 674-677.
10. Kuo PL, Chen YH, Chen TC, Shen KH, Hsu YL (2011) CXCL5/ENA78 increased cell migration and epithelial-to-mesenchymal transition of hormone-independent prostate cancer by early growth response-1/snail signaling pathway. J Cell Physiol 226: 1224-1231.
11. Salanga CL, Handel TM (2011) Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function. Exp Cell Res 317: 590-601.
12. Rot A (2010) Chemokine patterning by glycosaminoglycans and interceptors. Front Biosci 15: 645-660.
13. Colditz IG, Schneider MA, Pruenster M, Rot A (2007) Chemokines at large: invivo mechanisms of their transport, presentation and clearance. Thromb Haemost 97: 688-693. (Pubitemid 46779955)
14. Pickens SR, Chamberlain ND, Volin MV, Gonzalez M, Pope RM, et al. (2011) Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization. Angiogenesis 14: 443-455.
15. Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, et al. (1994) Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J Clin Invest 94: 1012-1018. (Pubitemid 24286441)
16. Dawes JM, Calvo M, Perkins JR, Paterson KJ, Kiesewetter H, et al. (2011) CXCL5 mediates UVB irradiation-induced pain. Sci Transl Med 3: 90ra60.
17. Li A, King J, Moro A, Sugi MD, Dawson DW, et al. (2011) Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer. Am J Pathol 178: 1340-1349.
18. Sattler M, Schleucher J, Griesinger C (1999) Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. pp. 93-158.
19. Goddard TD, Kneller DG (2008) SPARKY 3. University of California, San Francisco.
20. Mohan PM, Chakraborty S, Hosur RV (2009) Residue-wise conformational stability of DLC8 dimer from native-state hydrogen exchange. Proteins 75: 40-52.
21. Farrow NA, Muhandiram R, Singer AU, Pascal SM, Kay CM, et al. (1994) Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry 33: 5984-6003. (Pubitemid 24184605)
22. Rieping W, Habeck M, Bardiaux B, Bernard A, Malliavin TE, et al. (2007) ARIA2: automated NOE assignment and data integration in NMR structure calculation. Bioinformatics 23: 381-382. (Pubitemid 46323164)
23. Berjanskii MV, Neal S, Wishart DS (2006) PREDITOR: a web server for predicting protein torsion angle restraints. Nucleic Acids Res 34: W63-69. (Pubitemid 44529736)
24. Brünger AT, Adams PD, Clore GM, DeLano WL, Gros P, et al. (1998) Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54: 905-921.
25. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8: 477-486. (Pubitemid 126706801)
26. Koradi R, Billeter M, Wüthrich K (1996) MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 14: 51-55, 29-32.
27. Rajarathnam K, Kay CM, Dewald B, Wolf M, Baggiolini M, et al. (1997) Neutrophil-activating peptide-2 and melanoma growth-stimulatory activity are functional as monomers for neutrophil activation. J Biol Chem 272: 1725-1729. (Pubitemid 27043259)
28. Rajarathnam K, Kay CM, Clark-Lewis I, Sykes BD (1997) Characterization of quaternary structure of interleukin-8 and functional implications. Methods Enzymol 287: 89-105. (Pubitemid 27430235)
29. Burrows SD, Doyle ML, Murphy KP, Franklin SG, White JR, et al. (1994) Determination of the monomer-dimer equilibrium of interleukin-8 reveals it is a monomer at physiological concentrations. Biochemistry 33: 12741-12745. (Pubitemid 24352861)
30. Lowman HB, Fairbrother WJ, Slagle PH, Kabakoff R, Liu J, et al. (1997) Monomeric variants of IL-8: effects of side chain substitutions and solution conditions upon dimer formation. Protein Sci 6: 598-608. (Pubitemid 27120056)
31. Byeon IJ, Louis JM, Gronenborn AM (2003) A protein contortionist: core mutations of GB1 that induce dimerization and domain swapping. J Mol Biol 333: 141-152. (Pubitemid 37153271)
32. Sharma D, Rajarathnam K (2000) 13C NMR chemical shifts can predict disulfide bond formation. J Biomol NMR 18: 165-171.
33. Fairbrother WJ, Reilly D, Colby TJ, Hesselgesser J, Horuk R (1994) The solution structure of melanoma growth stimulating activity. J Mol Biol 242: 252-270. (Pubitemid 24303750)
34. Qian YQ, Johanson KO, McDevitt P (1999) Nuclear magnetic resonance solution structure of truncated human GRObeta [5-73] and its structural comparison with CXC chemokine family members GROalpha and IL-8. J Mol Biol 294: 1065-1072. (Pubitemid 30008781)
35. Clore GM, Appella E, Yamada M, Matsushima K, Gronenborn AM (1990) Three-dimensional structure of interleukin 8 in solution. Biochemistry 29: 1689-1696. (Pubitemid 20074708)
36. Rajarathnam K, Sykes BD, Dewald B, Baggiolini M, Clark-Lewis I (1999) Disulfide bridges in interleukin-8 probed using non-natural disulfide analogues: dissociation of roles in structure from function. Biochemistry 38: 7653-7658.
37. Kim KS, Clark-Lewis I, Sykes BD (1994) Solution structure of GRO/melanoma growth stimulatory activity determined by 1H NMR spectroscopy. J Biol Chem 269: 32909-32915.
38. Rajarathnam K, Clark-Lewis I, Dewald B, Baggiolini M, Sykes BD (1996) 1H NMR evidence that Glu-38 interacts with the N-terminal functional domain in interleukin-8. FEBS Lett 399: 43-46. (Pubitemid 27007948)
39. Willard L, Ranjan A, Zhang H, Monzavi H, Boyko RF, et al. (2003) VADAR: a web server for quantitative evaluation of protein structure quality. Nucleic Acids Res 31: 3316-3319. (Pubitemid 37442148)
40. Lowman HB, Slagle PH, DeForge LE, Wirth CM, Gillece-Castro BL, et al. (1996) Exchanging interleukin-8 and melanoma growth-stimulating activity receptor binding specificities. J Biol Chem 271: 14344-14352. (Pubitemid 26190332)
41. Rajagopalan L, Chin CC, Rajarathnam K (2007) Role of intramolecular disulfides in stability and structure of a noncovalent homodimer. Biophys J 93: 2129-2134. (Pubitemid 47437595)
42. Baldwin ET, Weber IT, St Charles R, Xuan JC, Appella E, et al. (1991) Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Proc Natl Acad Sci U S A 88: 502-506. (Pubitemid 21915493)
43. Maity H, Maity M, Krishna MM, Mayne L, Englander SW (2005) Protein folding: the stepwise assembly of foldon units. Proc Natl Acad Sci U S A 102: 4741-4746. (Pubitemid 40471524)
44. Li R, Woodward C (1999) The hydrogen exchange core and protein folding. Protein Sci 8: 1571-1590.
45. Joseph PR, Poluri KM, Gangavarapu P, Rajagopalan L, Raghuwanshi S, et al. (2013) Proline Substitution of Dimer Interface b-strand Residues as a Strategy for the Design of Functional Monomeric Proteins. Biophys J 105: 1491-1501.
46. Murphy PM (1997) Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin Hematol 34: 311-318.
47. Damaj BB, McColl SR, Neote K, Hébert CA, Naccache PH (1996) Diverging signal transduction pathways activated by interleukin 8 (IL-8) and related chemokines in human neutrophils. IL-8 and Gro-alpha differentially stimulate calcium influx through IL-8 receptors A and B. J Biol Chem 271: 20540-20544. (Pubitemid 26281829)
48. Rajagopalan L, Rajarathnam K (2006) Structural basis of chemokine receptor function - a model for binding affinity and ligand selectivity. Biosci Rep 26: 325-339. (Pubitemid 44730316)
49. Joseph PR, Sarmiento JM, Mishra AK, Das ST, Garofalo RP, et al. (2010) Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors. J Biol Chem 285: 29262-29269.
50. Joseph PR, Sawant KV, Isley A, Pedroza M, Garofalo RP, et al. (2013) Dynamic conformational switching in the chemokine ligand is essential for G Protein coupled-receptor activation. Biochem J.456: 241-251.
51. Park SH, Das BB, Casagrande F, Tian Y, Nothnagel HJ, et al. (2012) Structure of the chemokine receptor CXCR1 in phospholipid bilayers. Nature 491: 779-783.
52. Clark-Lewis I, Dewald B, Loetscher M, Moser B, Baggiolini M (1994) Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids. J Biol Chem 269: 16075-16081. (Pubitemid 24209294)
53. Hesselgesser J, Chitnis CE, Miller LH, Yansura DG, Simmons LC, et al. (1995) A mutant of melanoma growth stimulating activity does not activate neutrophils but blocks erythrocyte invasion by malaria. J Biol Chem 270: 11472-11476.
54. Ravindran A, Sawant KV, Sarmiento J, Navarro J, Rajarathnam K (2013) Chemokine CXCL1 dimer is a potent agonist for the CXCR2 receptor. J Biol Chem 288: 12244-12252.
55. Leong SR, Kabakoff RC, Hébert CA (1994) Complete mutagenesis of the extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged residues mediating IL-8 binding and signal transduction. J Biol Chem 269: 19343-19348. (Pubitemid 24233454)
56. Young H, Roongta V, Daly TJ, Mayo KH (1999) NMR structure and dynamics of monomeric neutrophil-activating peptide 2. Biochem J 338 (Pt 3): 591-598. (Pubitemid 29140061)
57. Rajarathnam K, Clark-Lewis I, Sykes BD (1995) 1H NMR solution structure of an active monomeric interleukin-8. Biochemistry 34: 12983-12990.
58. Levashova ZB, Sharma N, Timofeeva OA, Dome JS, Perantoni AO (2007) ELR+-CXC chemokines and their receptors in early metanephric development. J Am Soc Nephrol 18: 2359-2370. (Pubitemid 47208110)
59. Nufer O, Corbett M, Walz A (1999) Amino-terminal processing of chemokine ENA-78 regulates biological activity. Biochemistry 38: 636-642.
60. Mortier A, Loos T, Gouwy M, Ronsse I, Van Damme J, et al. (2010) Posttranslational modification of the NH2-terminal region of CXCL5 by proteases or peptidylarginine Deiminases (PAD) differently affects its biological activity. J Biol Chem 285: 29750-29759.
61. Gangavarapu P, Rajagopalan L, Kolli D, Guerrero-Plata A, Garofalo RP, et al. (2012) The monomer-dimer equilibrium and glycosaminoglycan interactions of chemokine CXCL8 regulate tissue-specific neutrophil recruitment. J Leukoc Biol 91: 259-265.
62. Das ST, Rajagopalan L, Guerrero-Plata A, Sai J, Richmond A, et al. (2010) Monomeric and dimeric CXCL8 are both essential for in vivo neutrophil recruitment. PLoS One 5: e11754.
63. Tanino Y, Coombe DR, Gill SE, Kett WC, Kajikawa O, et al. (2010) Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs. J Immunol 184: 2677-2685.
64. Poluri KM, Joseph PR, Sawant KV, Rajarathnam K (2013) Molecular Basis of Glycosaminoglycan Heparin Binding to the Chemokine CXCL1 Dimer. J Biol Chem 288: 25143-25153.